Gene · 9900
Papers2,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of ABBV-552 Safety and Pharmacokinetics in Healthy Asian and Western Adults. | Clin Pharmacol Drug Dev | 2026 | 42387856 | PubTator, text mining | PubMed |
| Clinical drug-oriented design, synthesis, and pharmacological evaluation of novel dual-target antiepileptic hybrid molecules. | Bioorg Chem | 2026 | 42385394 | PubTator, text mining | PubMed |
| Synaptic Plasticity-Intrinsic Excitability and Antidepressant Discovery. | Biomedicines | 2026 | 42351693 | PubTator, text mining | PubMed |
| Sleep deprivation increases levels of the synaptic density marker SV2A in the human brain. | PLoS Biol | 2026 | 42335020 | PubTator, text mining | PubMed |
| Transcriptomic signatures of synaptic loss in Alzheimer's disease. | iScience | 2026 | 42317388 | PubTator, text mining | PubMed |
| Quantification of 18F-SynVesT-1 binding in healthy aging and head-to-head comparison with 11C-UCB-J. | J Cereb Blood Flow Metab | 2026 | 42219995 | PubTator, text mining | PubMed |
| Facile synthesis of (4-phenylthiophen-2-yl)methyl 1-naphthoates via Suzuki-Miyaura cross-coupling: anti-seizure evaluation through molecular docking, EEG analysis, and ADMET profiling. | RSC Adv | 2026 | 42181711 | PubTator, text mining | PubMed |
| Automated GMP production and long-term experience in radiosynthesis of the SV2A tracer [11C]UCB-J. | EJNMMI Radiopharm Chem | 2026 | 42154186 | PubTator, text mining | PubMed |
| Lower synaptic density in mood circuitry underlies depression in Parkinson's disease. | Brain Commun | 2026 | 42109687 | PubTator, text mining | PubMed |
| Efficacy and safety of Brivaracetam as an adjunctive therapy in patients with focal-onset seizures: a phase III, multi-center, randomized, double-blind, placebo-controlled trial. | Acta Epileptol | 2026 | 42092987 | PubTator, text mining | PubMed |
| HIV-1 Tat expression drives progressive synaptic decline: evidence from longitudinal [11C]-UCB-J PET imaging. | NeuroImmune Pharm Ther | 2026 | 42058368 | PubTator, text mining | PubMed |
| Brivaracetam-associated manic episode in a patient with bipolar disorder: A case report. | PCN Rep | 2026 | 42052576 | PubTator, text mining | PubMed |
| Integrated transient chromophores for efficient photo-induced radiofluorination. | Chem | 2026 | 42028336 | PubTator, text mining | PubMed |
| Autoradiographic assessment of SynVesT-1 revealed changes in non-displaceable binding with demyelination and remyelination: implications for SV2A PET analysis. | EJNMMI Res | 2026 | 41995918 | PubTator, text mining | PubMed |
| Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET. | Transl Psychiatry | 2026 | 41986308 | PubTator, text mining | PubMed |
| Detection of Synaptic Vesicle Glycoprotein 2A in Serum Using a Polypyrrole-Functionalized Graphene Oxide Electrochemical Immunosensor. | Nanomaterials (Basel) | 2026 | 41972613 | PubTator, text mining | PubMed |
| Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison of 1 8F-SynVesT-1 and 1 8F-FDG PET. | Alzheimers Dement | 2026 | 41954197 | PubTator, text mining | PubMed |
| Detection of Focal Lesions in Epilepsy with [18F]UCB-H Synaptic Vesicle Protein 2A PET Imaging. | J Nucl Med | 2026 | 41927278 | PubTator, text mining | PubMed |
| Synaptic loss in alcohol use disorder: clinical and mechanistic insights from a PET imaging study. | J Clin Invest | 2026 | 41919494 | PubTator, text mining | PubMed |
| RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage. | Toxins (Basel) | 2026 | 41893557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9900/papers?page=2